Mechanisms of BRCA1 Tumor Suppression

被引:116
作者
Silver, Daniel P. [1 ,2 ]
Livingston, David M. [1 ,3 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[3] Dana Farber Canc Inst, Dept Genet, Boston, MA 02215 USA
关键词
DNA-DAMAGE RESPONSE; INACTIVE X-CHROMOSOME; BREAST-CANCER; MUTATION CARRIERS; OVARIAN CARCINOMAS; CELL FATE; XIST RNA; PROTEIN; REPAIR; RESISTANCE;
D O I
10.1158/2159-8290.CD-12-0221
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p220 BRCA1 tumor suppressor protein has been implicated in multiple biochemical and biologic functions since its molecular cloning 18 years ago. Here, we discuss those functions most relevant for its tumor-suppressing activities with an emphasis on new findings. In particular, this review focuses on what is known of the activities of those BRCA1-binding partners that have tumor suppressor functions, on the reversion of mutant BRCA1 alleles concomitant with therapy resistance, on insights gained from studies of BRCA1 structure-function relationships, recent findings from animal models, and the potential role of BRCA1 in some nonhereditary tumors. From this information, a more detailed and refined picture of BRCA1 tumor suppression is beginning to emerge. Although key mysteries remain-such as why BRCA1 tumor suppression is focused on carcinomas of the breast and ovary-the pace of discovery is increasing. Significance: BRCA1 functions as a clinically important classical tumor suppressor in hereditary breast and ovarian cancer; here, we review progress in understanding how BRCA1 operates to suppress tumor formation. Cancer Discov; 2(8);679-84. (C) 2012 AACR.
引用
收藏
页码:679 / 684
页数:6
相关论文
共 53 条
[1]   Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents [J].
Birkbak, Nicolai J. ;
Wang, Zhigang C. ;
Kim, Ji-Young ;
Eklund, Aron C. ;
Li, Qiyuan ;
Tian, Ruiyang ;
Bowman-Colin, Christian ;
Li, Yang ;
Greene-Colozzi, April ;
Iglehart, J. Dirk ;
Tung, Nadine ;
Ryan, Paula D. ;
Garber, Judy E. ;
Silver, Daniel P. ;
Szallasi, Zoltan ;
Richardson, Andrea L. .
CANCER DISCOVERY, 2012, 2 (04) :366-375
[2]   BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer [J].
Bochar, DA ;
Wang, L ;
Beniya, H ;
Kinev, A ;
Xue, YT ;
Lane, WS ;
Wang, WD ;
Kashanchi, F ;
Shiekhattar, R .
CELL, 2000, 102 (02) :257-265
[3]   Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients [J].
Byrski, T. ;
Huzarski, T. ;
Dent, R. ;
Gronwald, J. ;
Zuziak, D. ;
Cybulski, C. ;
Kladny, J. ;
Gorski, B. ;
Lubinski, J. ;
Narod, S. A. .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (02) :359-363
[4]   BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function [J].
Cantor, SB ;
Bell, DW ;
Ganesan, S ;
Kass, EM ;
Drapkin, R ;
Grossman, S ;
Wahrer, DCR ;
Sgroi, DC ;
Lane, WS ;
Haber, DA ;
Livingston, DM .
CELL, 2001, 105 (01) :149-160
[5]   Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells [J].
Chen, JJ ;
Silver, DP ;
Walpita, D ;
Cantor, SB ;
Gazdar, AF ;
Tomlinson, G ;
Couch, FJ ;
Weber, BL ;
Ashley, T ;
Livingston, DM ;
Scully, R .
MOLECULAR CELL, 1998, 2 (03) :317-328
[6]   A deletion at the mouse Xist gene exposes trans-effects that alter the heterochromatin of the inactive X chromosome and the replication time and DNA stability of both X chromosomes [J].
Diaz-Perez, Silvia V. ;
Ferguson, David O. ;
Wang, Chen ;
Csankovszki, Gyorgyi ;
Wang, Chengming ;
Tsai, Shih-Chang ;
Dutta, Devkanya ;
Perez, Vanessa ;
Kim, SunMin ;
Eller, C. Daniel ;
Salstrom, Jennifer ;
Ouyang, Yan ;
Teitell, Michael A. ;
Kaltenboeck, Bernhard ;
Chess, Andrew ;
Huang, Sui ;
Marahrens, York .
GENETICS, 2006, 174 (03) :1115-1133
[7]   BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance [J].
Drost, Rinske ;
Bouwman, Peter ;
Rottenberg, Sven ;
Boon, Ute ;
Schut, Eva ;
Klarenbeek, Sjoerd ;
Klijn, Christiaan ;
van der Heijden, Ingrid ;
van der Gulden, Hanneke ;
Wientjens, Ellen ;
Pieterse, Mark ;
Catteau, Aurelie ;
Green, Pete ;
Solomon, Ellen ;
Morris, Joanna R. ;
Jonkers, Jos .
CANCER CELL, 2011, 20 (06) :797-809
[8]   Resistance to therapy caused by intragenic deletion in BRCA2 [J].
Edwards, Stacey L. ;
Brough, Rachel ;
Lord, Christopher J. ;
Natrajan, Rachael ;
Vatcheva, Radost ;
Levine, Douglas A. ;
Boyd, Jeff ;
Reis-Filho, Jorge S. ;
Ashworth, Alan .
NATURE, 2008, 451 (7182) :1111-U8
[9]   BRCA1 inhibition of estrogen receptor signaling in transfected cells [J].
Fan, S ;
Wang, JA ;
Yuan, R ;
Ma, Y ;
Meng, Q ;
Erdos, MR ;
Pestell, RG ;
Yuan, F ;
Auborn, KJ ;
Goldberg, ID ;
Rosen, EM .
SCIENCE, 1999, 284 (5418) :1354-1356
[10]   Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [J].
Farmer, H ;
McCabe, N ;
Lord, CJ ;
Tutt, ANJ ;
Johnson, DA ;
Richardson, TB ;
Santarosa, M ;
Dillon, KJ ;
Hickson, I ;
Knights, C ;
Martin, NMB ;
Jackson, SP ;
Smith, GCM ;
Ashworth, A .
NATURE, 2005, 434 (7035) :917-921